Important new human trial results
A published human trial that genuinely changes what can be said about a compound — not a press release, not a conference teaser.
Evidence Watch
The evidence changes. We'll tell you when it actually matters.
Get notified when important peptide evidence, regulatory status, or major trial findings change. No daily noise. No supplier promotions. Just meaningful changes to the evidence.
Join the list
Email address only. No account, no login, nothing else to fill in.
What we'll actually send
Three kinds of change. Nothing else.
Regulatory or licensing changes
An approval, a withdrawal, a restriction, or a licensing change in a major region. Legal status is not proof of effectiveness or safety, and we'll say so.
Material changes to Registry evidence ratings
When our reading of the evidence moves, and why. A rating changing means the assessment changed — not that the compound itself became better, worse or safer.
What this is not
- Not daily marketing. There is no content schedule to fill. If nothing important changed, nothing gets sent.
- Not medical advice. Evidence Watch explains research. It never gives dosing, protocols or personalised recommendations.
- Not supplier or promotional content. We do not endorse, review or link to suppliers or grey-market sources, and we do not sell subscriber data.
Educational information only
Evidence Watch is an alerting service for people who want to follow the research. It is not medical advice, and it is not a substitute for a qualified clinician. Please don’t send us personal health information.